Fear of cancer recurrence and perceived pain in patients with breast cancer: A network analysis approach

乳腺癌患者对癌症复发的恐惧和感知疼痛:一种网络分析方法

阅读:1

Abstract

OBJECTIVE: This study aimed to identify core symptom nodes and examine directional relationships within the networks of fear of cancer recurrence (FCR) and pain catastrophizing (PC), and to investigate high-impact targets for intervention. METHODS: From September to November 2024, a total of 346 eligible patients with breast cancer were enrolled from a multi-center trial named as Be Resilient to Breast Cancer (BRBC). The Fear of Cancer Recurrence Inventory and the Pain Catastrophizing Scale was used to collect data. A Gaussian network analysis was performed to identify the key components for FCR, PC and the connections between them. Bayesian networks were used to identify pathways of symptom activation at the symptom-level network architecture, and computer-simulated interventions were used to identify specific intervention targets. RESULTS: In the analysis of separate networks, "Severity" emerged as the primary component of FCR, exhibiting the highest centrality metrics. For the PC, "Terrible" was identified as the central symptom, with notable centrality values. The dimension "Assurance" and the item "Awful" served as critical bridging elements, facilitating the interaction between FCR and PC when they co-occur. Bayesian network analysis identified 36 directed edges, with "Insight" in FCR and "Anxious" in PC acting as parent nodes, indicating their influential roles in the network structure. Computer-simulated interventions demonstrated that amplifying the "Terrible" node in PC maximized the total score and network connectivity. Conversely, attenuating the "Triggers" node in FCR minimized the total score. CONCLUSIONS: This study demonstrates that FCR and PC exhibit distinct network structures, which have their own specific core symptoms and corresponding core bridging nodes when the two coexist. This may serve as primary targets for personalized interventions for patients with breast cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。